DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

55.37 0.42 (0.76%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MRK $55.37 0.76%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $54.78
Previous Close $54.95
Daily Range $54.59 - $55.41
52-Week Range $45.69 - $63.62
Market Cap $156.0B
P/E Ratio 16.21
Dividend (Yield) $1.80 (3.3%)
Ex-Dividend Date
Dividend Pay Date
09/11/15
10/07/15
Volume 12,796,949
Average Daily Volume 10,929,795
Current FY EPS $3.51

Sector

Healthcare

Industry

Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary Rss Feed

Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?

Are DPP-4 inhibitors like Januvia on their way out? A new long-term study from partners Eli Lilly and Boehringer Ingelheim suggests it's a possibility.

An 80/20 Filter On How The DJIA Weathered The Week

The Zacks Analyst Blog Highlights: Merck & Co, Apple, Visa, Microsoft and Intel

Novo Nordisk to Start PIONEER Program on Semaglutide

5 Stocks That Led Dow to 3rd Biggest Gain

JNJ’s Splenda Sale Shouldn’t Be A Concern For Investors

Eli Lilly's Diabetes Drug May Halt Heart Disease

Eli Lilly's Jardiance was shown to reduce the risk of heart attack and stroke in diabetics.

The 4 Stocks That Boosted the DJIA on Wednesday

Trade-Ideas: Merck (MRK) Is Today's "Dead Cat Bounce" Stock

Short Sellers Have Mixed Feelings on Major Pharma

See More MRK News...

MRK's Top Competitors

MRK $55.37 (0.76%)
Current stock: MRK
JNJ $95.17 (-1.09%)
Current stock: JNJ
NVS $98.35 (-0.29%)
Current stock: NVS
RHHBY $34.16 (-1.98%)
Current stock: RHHBY